-
Sensex, Nifty inch lower in early trade; pharma stocks drag
IndusInd Bank, diving over 10%, was the top Sensex loser followed by Asian Paints, Sun Pharma, M&M, Reliance Industries and HDFC Bank
-
Markets close at fresh highs; metals, pharma stocks gain
Sensex settled 175.62 points or 0.31% higher at 56,124.72, while the broader NSE Nifty gained 68.30 points or 0.41% to close at a record 16,705.20
-
Be high on consumption, pharma, IT stocks: JM Financial
JM Financial maintains a precautionary view on the small and mid cap indices, which have made new highs on relative valuation against Nifty50
-
Should you buy, sell or hold Dr Reddy’s post sharp fall?
The pharma major reported a consolidated profit of Rs 570.8 crore for the quarter ended June 2021, 1.5% down from the year-ago period
-
Markets slip for the 3rd straight week on Covid concerns; here’s what to expect the next week
On Friday, after a highly volatile trading session, the Sensex closed at 47,878.45, down 202.22 points, or 0.42%
-
Aurobindo Pharma shares extend gain for fifth straight session
Nifty Pharma index of which Aurobindo Pharma Ltd is a constituent, has gained around 13.41% in last one month and is currently quoting at 13426.9, up
-
Dr Reddys Laboratories Ltd soars 1.8%, up for fifth straight session
The stock is quoting at Rs 5249.5, up 1.8% on the day as on 12:49 IST on the NSE.
-
Cadila Healthcare soars 1.18%, gains for fifth straight session
Cadila Healthcare Ltd is quoting at Rs 562.8, up 1.18% on the day as on 12:49 IST on the NSE. The stock is up 69.8% in last one year as compared to a
-
Pharma stocks outperform as Covid-19 cases spike; what’s next?
With a rally of 2.28%, Dr Reddy’s Laboratories emerged as the top gainer in the index
